Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-020478

Options or other derivatives

  • CEO acquired 225,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

PIMSTONE SIMON N. · CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-12 Grant or award : show line 1 in the form Stock Option (Right to Buy) +225,000 225,000 D
Loading xslF345X03/doc4.xml…